Stocks in Play: Theratechnologies Inc.
Wednesday, March 12, 2025
11:19 AM EST - Theratechnologies Inc. : Today presented data from a real-world, observational, registry study demonstrating the efficacy and safety of ibalizumab in reducing HIV RNA to undetectable levels in heavily treatment-experienced (HTE) patients with multidrug resistant HIV. Theratechnologies Inc. (T.TH) shares were up $0.03 at 2.21.Stocks in Play: Theratechnologies Inc., Wed, 12 Mar 2025 11:57:07 EST
